Mika Tanaka

Title: Innovations of Mika Tanaka in Geminivirus Disease Control

Introduction

Mika Tanaka is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of plant disease control, particularly in combating geminivirus diseases. Her innovative work has led to the development of a unique peptide that plays a crucial role in disease management.

Latest Patents

Mika Tanaka holds a patent for a peptide effective in the control of geminivirus disease. The patent describes a decoy peptide, which is a partial peptide of ASYMMETRIC LEAVES1 (AS1). This decoy peptide is capable of interacting with βC1, which is encoded by a betasatellite of a virus belonging to the family Geminiviridae. The patent also includes a nucleic acid encoding the decoy peptide, an expression vector comprising the nucleic acid, and a geminivirus disease control agent that utilizes the decoy peptide or the nucleic acid. Furthermore, it outlines methods for controlling geminivirus diseases and evaluating the reduction of disease symptoms caused by viruses in this family.

Career Highlights

Mika Tanaka is associated with Ishihara Sangyo Kaisha, Ltd., where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on agricultural practices and plant health.

Collaborations

Mika collaborates with notable colleagues, including Yasunori Machida and Norifusa Matsuo. Their combined expertise contributes to the ongoing research and development in the field of plant disease control.

Conclusion

Mika Tanaka's innovative contributions to the control of geminivirus diseases highlight her role as a leading inventor in agricultural biotechnology. Her work not only addresses critical challenges in plant health but also paves the way for future advancements in disease management.